Huadong Medicine Co., Ltd (SHE:000963)
China
· Delayed Price · Currency is CNY 43.21
+0.87 (2.05%)
May 23, 2025, 2:45 PM CST
Huadong Medicine Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 22, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 75,910 | 60,553 | 72,565 | 82,087 | 70,342 | 46,475 | Upgrade
|
| Market Cap Growth | 18.37% | -16.55% | -11.60% | 16.70% | 51.35% | 8.94% | Upgrade
|
| Enterprise Value | 75,369 | 58,711 | 70,923 | 81,583 | 69,341 | 46,024 | Upgrade
|
| Last Close Price | 43.38 | 34.60 | 40.19 | 45.04 | 38.42 | 25.25 | Upgrade
|
| PE Ratio | 21.35 | 17.24 | 25.56 | 32.85 | 30.56 | 16.48 | Upgrade
|
| Forward PE | 17.74 | 19.83 | 27.57 | 30.39 | 29.34 | 13.64 | Upgrade
|
| PS Ratio | 1.80 | 1.45 | 1.79 | 2.18 | 2.04 | 1.38 | Upgrade
|
| PB Ratio | 3.09 | 2.57 | 3.36 | 4.28 | 4.15 | 3.06 | Upgrade
|
| P/TBV Ratio | 4.37 | 3.67 | 4.50 | 5.92 | 5.76 | 3.98 | Upgrade
|
| P/FCF Ratio | 50.34 | 29.96 | 31.24 | 69.06 | 29.92 | 23.98 | Upgrade
|
| P/OCF Ratio | 22.32 | 16.15 | 18.47 | 34.46 | 22.19 | 13.62 | Upgrade
|
| PEG Ratio | 1.13 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | Upgrade
|
| EV/Sales Ratio | 1.78 | 1.40 | 1.75 | 2.16 | 2.01 | 1.37 | Upgrade
|
| EV/EBITDA Ratio | 14.49 | 11.53 | 16.43 | 21.60 | 20.91 | 13.32 | Upgrade
|
| EV/EBIT Ratio | 17.30 | 13.53 | 19.76 | 25.86 | 24.71 | 15.22 | Upgrade
|
| EV/FCF Ratio | 49.99 | 29.05 | 30.54 | 68.64 | 29.50 | 23.74 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.13 | 0.09 | 0.14 | 0.12 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | 0.51 | 0.58 | 0.44 | 0.67 | 0.61 | 0.58 | Upgrade
|
| Debt / FCF Ratio | 1.77 | 1.50 | 0.83 | 2.17 | 0.89 | 1.03 | Upgrade
|
| Asset Turnover | 1.14 | 1.17 | 1.26 | 1.30 | 1.35 | 1.48 | Upgrade
|
| Inventory Turnover | 6.11 | 6.18 | 6.25 | 6.07 | 5.96 | 5.57 | Upgrade
|
| Quick Ratio | 1.17 | 1.15 | 1.28 | 1.23 | 1.21 | 1.19 | Upgrade
|
| Current Ratio | 1.56 | 1.53 | 1.71 | 1.73 | 1.67 | 1.70 | Upgrade
|
| Return on Equity (ROE) | 15.08% | 15.48% | 13.97% | 14.02% | 14.56% | 20.75% | Upgrade
|
| Return on Assets (ROA) | 7.37% | 7.60% | 6.94% | 6.78% | 6.85% | 8.28% | Upgrade
|
| Return on Capital (ROIC) | 10.59% | 10.83% | 9.91% | 9.67% | 9.69% | 11.77% | Upgrade
|
| Return on Capital Employed (ROCE) | 17.40% | 18.00% | 15.80% | 15.00% | 15.80% | 19.40% | Upgrade
|
| Earnings Yield | 4.70% | 5.80% | 3.91% | 3.04% | 3.27% | 6.07% | Upgrade
|
| FCF Yield | 1.99% | 3.34% | 3.20% | 1.45% | 3.34% | 4.17% | Upgrade
|
| Dividend Yield | 2.74% | 2.69% | 1.44% | 0.64% | 0.76% | 0.91% | Upgrade
|
| Payout Ratio | 47.23% | 48.47% | 20.93% | 23.07% | 19.99% | 20.06% | Upgrade
|
| Buyback Yield / Dilution | -0.15% | -0.08% | -0.10% | -0.00% | 0.00% | -0.00% | Upgrade
|
| Total Shareholder Return | 2.60% | 2.60% | 1.34% | 0.64% | 0.76% | 0.91% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.